Jose L. Labandeira-Garcia

[Anairp @Anai_rp]

📢 🔬The latest article from @LabandeiraL (@cimususc @UniversidadeUSC @red_terav @ciberned) "Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia" is just out in @antioxidants_OA ‼️👇
https://t.co/X5zYR22CPF

[Anairp @Anai_rp]

📢📢🔬 The latest results of @LabandeiraL Lab (@UnistemSantiago , @cimususc , @UniversidadeUSC ) show that Angiotensin receptor autoantibodies are a link between MetS and #Parkinson’s disease. Check out in @BrainBehavImm 👇
https://t.co/u47yteg8yQ

[The Science of Parkinson's @ScienceofPD]

Follow up research from @CarmenLabandeir @LabandeiraL & colleagues showing angiotensin receptor type 1 autoantibodies increase nigral proinflammatory activity & neurodegeneration in preclinical models of #Parkinsons
https://t.co/wRt0wgfwH9

[Anairp @Anai_rp]

👩‍🎓Felicidades a @CarmenLabandeir, nuestra recién estrenada doctora de @UnistemSantiago (en @cimususc de @UniversidadeUSC) y @Com_CHUO por su brillante defensa de la tesis: "Autoinmunidad y SRA en la Enfermedad de Parkinson"
📎https://t.co/h4GEEw22II

[Anairp @Anai_rp]

Enhorabuena a nuestra compañera @CarmenLabandeir de @UnistemSantiago (en @cimususc; @UniversidadeUSC ) y @Com_CHUO por su trabajo. Hoy @lavozdegalicia se hace eco de sus hallazgos y permite acercar a la sociedad el fruto de su arduo trabajo.
https://t.co/B3dxpjf52y

[Anairp @Anai_rp]

💊💊Vías gallegas contra el #Parkinson. @Farodevigo nos acerca a la investigación de @CarmenLabandeir (@cimususc en @UniversidadeUSC y @Com_CHUO) que profundiza en el estudio de fármacos contra #sindromemetabólico y #diabetes en el Parkinson.👇
https://t.co/gGUw9xI3Dz

[Anairp @Anai_rp]

🩺🔬El trabajo de nuestra investigadora clínica @CarmenLabandeir de @cimususc (@UniversidadeUSC ) y @Com_CHUO sobre reposición de fármacos antihipertensivos y antidiabéticos para el tratamiento del #Parkinson en @LaRegion
https://t.co/oL7nRxtKJB

[Anairp @Anai_rp]

Investigan la eficacia de fármacos contra la diabetes en el párkinson https://t.co/7TMgRXfohG

[USC @UniversidadeUSC]

🔬Unha investigación do @cimususc avalía o uso de fármacos antihipertensivos no tratamento da enfermidade de #Parkinson

As achegas son froito da tese de doutoramento que a neuróloga @CarmenLabandeir desenvolveu na @UniversidadeUSC

🗞️ https://t.co/m8Gv52K4ug

[Anairp @Anai_rp]

Un trabajo colaborativo del @UnistemSantiago
(@cimususc, @UniversidadeUSC) y del @Com_CHUO estudia la posible utilidad de fármacos contra el #síndromemetabólico o la #diabetes en el tratamiento del #Parkinson.
https://t.co/lXJyDRAFPD

[Anairp @Anai_rp]

@LabandeiraL, from @CIBERNED, @cimususc and @UniversidadeUSC publishes in @MDJ_Journal the host topic "Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene". Find out by reading 👇👇
https://t.co/z4zLOYKLPZ

[The Science of Parkinson's @ScienceofPD]

AT1 autoantibodies also increased levels of neuroinflammation markers, which was inhibited by the AT1 antagonist candesartan; The autoantibodies were also found in PD cerebrospinal fluid; Further support for repurposing angiotensin type-1 receptor blockers for #Parkinsons?

[Anairp @Anai_rp]

📢📢🔬More about Renin Angiotensin System Autoantibodies in #Covid_19. Find out by reading our latest paper published in @FrontMedicine. @CarmenLabandeir, @LabandeiraL, @UnistemSantiago, @JUANSUAREZQUINT, @cimususc, @UniversidadeUSC.👇👇👇
https://t.co/Wrpfw4dNt1

[Antioxidants MDPI @antioxidants_OA]

👏Congratulations to all the authors Quijano et al. @Anai_rp @LabandeiraL from @UnistemSantiago @cimususc @UniversidadeUSC for your new publication via @antioxidants_OA

📚Read via https://t.co/Uktgpy3uuE…

#antioxidants #inflammasome #neurodegeneration

[Anairp @Anai_rp]

📢Check out our new article, "Drugs modulating Renin-Angiotensin System in COVID-19 Treatment" published in @Biomed_MDPI by @LabandeiraL and colleagues. @cimususc; @UniversidadeUSC; @UnistemSantiago.
It is available for reading in 👇
https://t.co/fL66p1Xh1F

[Anairp @Anai_rp]

📢📢 Check out the commentary about our article published in Clinical Science @PPPublishing.
@LabandeiraL;@CiberUb; @CarmenLabandeir; @RitaValenLimi; @cimususc; @UniversidadeUSC; @UnistemSantiago
Thanks to the authors Fedor Simko and Tomas Baka
👇 https://t.co/3BCs9cwuVB

[Anairp @Anai_rp]

Check out the new paper of our partner @CarmenLabandeir "Parkinson´s disease and diabetes mellitus: common mechanisms and treatment repurposing" published in @NRRNeural 👇👇👇https://t.co/hCkrOFljmO